1 – 22 of 22
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Associations of clinical, psychological, and sociodemographic characteristics and ecological momentary assessment completion in the 10-week Hypo-METRICS study : Hypoglycaemia MEasurements ThResholds and ImpaCtS
2024) In Diabetic Medicine(
- Contribution to journal › Article
- 2020
-
Mark
Swedish national guideline for prevention and treatment of neonatal hypoglycaemia in newborn infants with gestational age ≥35 weeks
(
- Contribution to journal › Scientific review
-
Mark
Importance of gestational hypoglycaemia for foetal malformations and skeletal development in rats
(
- Contribution to journal › Article
- 2019
-
Mark
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
(
- Contribution to journal › Article
-
Mark
Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
(
- Contribution to journal › Article
- 2018
-
Mark
Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes : A randomized, placebo-controlled study
(
- Contribution to journal › Article
- 2017
-
Mark
Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes : A randomized, open-label, 2-arm parallel comparative, exploratory trial
(
- Contribution to journal › Article
- 2011
-
Mark
Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
(
- Contribution to journal › Scientific review
- 2010
-
Mark
Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
(
- Contribution to journal › Article
- 2009
-
Mark
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
(
- Contribution to journal › Article
- 2008
-
Mark
The osmotic link between hypoglycaemia and hypovolaemia
(
- Contribution to journal › Article
- 2007
-
Mark
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
(
- Contribution to journal › Article
- 2001
-
Mark
Hypothalamic-pituitary-adrenal response to different tests in type 1 diabetes mellitus
(
- Contribution to journal › Article
- 1999
-
Mark
Human glycogen synthase genes. Role in insulin resistance and hypoglycaemia
1999)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Applications of event-related potentials in the study of attention
1999)(
- Thesis › Doctoral thesis (compilation)
- 1998
-
Mark
Hypoglycaemia leads to an increased QT interval in normal men
(
- Contribution to journal › Article
- 1994
-
Mark
BDNF makes cultured dentate granule cells more resistant to hypoglycemic damage
(
- Contribution to journal › Article
- 1993
-
Mark
The influence of hypoglycaemia on regional cerebral blood flow and cerebral volume in type 1 (insulin-dependent) diabetes mellitus
(
- Contribution to journal › Article
- 1990
-
Mark
Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man
(
- Contribution to journal › Article
-
Mark
Extracellular levels of quinolinic acid are moderately increased in rat neostriatum following severe insulin-induced hypoglycaemia
(
- Contribution to journal › Article
- 1989
-
Mark
Cerebral complications detected by EEG-monitoring during neonatal intensive care
(
- Contribution to journal › Article